Literature DB >> 7814203

Laser sclerostomy ab interno using continuous wave and pulsed lasers in a rabbit model.

W Wetzel1, M Scheu.   

Abstract

PURPOSE: This experimental study was designed to find an optimal combination of parameters for a gonioscopic ab interno approach to laser sclerostomy.
METHODS: Laser sclerostomy ab interno was performed delivering the laser energy via a slit lamp and a gonioscopic contact lens to the iridocorneal angle. The laser energy is required to be well transmitted by the cornea and at the same time to be maximally absorbed by the sclera at the iridocorneal angle. For local enhancement of absorption the sclera was stained with the biocompatible dyes Fluorescein (absorption maximum at 480 nm) and Methylene blue (absorption maximum at 668 nm) applied by iontophoresis. A continuous-wave (cw)-Argon laser and a cw-dye laser produced relatively long pulses (200 ms) at wavelengths matching with these respective maxima. Additionally a pulsed dye laser emitting shorter pulses (2 microseconds) was successively adapted to the wavelengths of the two maxima. In some cases a Q-switched Nd: YAG laser had to be used for perforation of Descemet's membrane. A total of 44 rabbit eyes was treated to compare the results for these four different laser/dye combinations.
RESULTS: While no successfull perforation of the sclera could be achieved using the cw-dye laser with scleral staining by Methylene blue, the intraoperative success rate ranged between 59% and 75% for the other three laser/dye combinations. Histological examinations of the eyes on the first postoperative day showed smaller thermal necrosis zones, but more often fibrin reactions when using the shorter pulse length. Although we often found iris adherences to the internal fistula ostium, no major complications were observed.
CONCLUSION: Further improvement of intraoperative success rates is needed, before clinical application of the approach can be considered.

Entities:  

Mesh:

Year:  1994        PMID: 7814203     DOI: 10.1007/bf00919242

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

1.  Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit.

Authors:  M H Miller; I Grierson; W I Unger; R A Hitchings
Journal:  Ophthalmic Surg       Date:  1989-05

2.  Laser sclerostomy ab interno using a continuous wave Nd:YAG laser.

Authors:  J C Javitt; S S O'Connor; R P Wilson; J L Federman
Journal:  Ophthalmic Surg       Date:  1989-08

3.  External limbal sclerostomy with contact Nd:YAG laser versus surgical knife.

Authors:  M E Tawakol; G A Peyman; M Oncel; B Khoobehi
Journal:  Int Ophthalmol       Date:  1989-05       Impact factor: 2.031

4.  Ab interno sclerostomy with a high-powered argon endolaser.

Authors:  G J Jaffe; G A Williams; W F Mieler; R L Radius
Journal:  Am J Ophthalmol       Date:  1988-10-15       Impact factor: 5.258

5.  Internal sclerostomy with the Nd: YAG contact laser versus thermal sclerostomy in rabbits.

Authors:  E J Higginbotham; G Kao; G Peyman
Journal:  Ophthalmology       Date:  1988-03       Impact factor: 12.079

6.  Silver oxide in YAG sclerostomy.

Authors:  W F March; R P Shaver; T Gherezghiher; R E Nordquist
Journal:  Lasers Surg Med       Date:  1987       Impact factor: 4.025

7.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

8.  [Elliot's trepanation with scleral cover (procedure for protecting the fistula in Elliot's trepanation with a lamellar scleral cover)].

Authors:  J Fronimopoulos; N Lambrou; N Pelekis; C Christakis
Journal:  Klin Monbl Augenheilkd       Date:  1970       Impact factor: 0.700

9.  Experimental YAG laser sclerostomy.

Authors:  W F March; T Gherezghiher; M C Koss; R E Nordquist
Journal:  Arch Ophthalmol       Date:  1984-12

10.  Gonioscopic ab interno laser sclerostomy. A pilot study in glaucoma patients.

Authors:  M A Latina; S Melamed; W F March; M A Kass; A E Kolker
Journal:  Ophthalmology       Date:  1992-11       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.